UCB - Lucro Operacional

Preço das Ações
234.90
Mudança Diária
5.00 2.17%
Mensal
-9.31%
Anual
45.81%
Q2 Previsão
231.88




Lucro Operacional Alterar Data
Alcon AG USD 297M 16M 2026-03
Almirall EUR 30.23M 12.8M 2025-12
Amarin USD -2.26M 564K 2025-12
argenx SE USD 394M 22.86M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Genmab DKK 260M 199M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 249M 26.38M 2026-03
Hikma Pharmaceutical USD 348M 161M 2025-12
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Lonza CHF 673M 243M 2025-06
Merck EUR 1.05B 572M 2026-03
Novartis USD 4.24B 171M 2026-03
Orion EUR 114.8M 213.4M 2026-03
Recordati EUR 231.11M 47.11M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12
Unibail Rodamco EUR 844.1M 102.4M 2025-12